Share Search

Angle Share News

Share Price: 52.00   Bid / Ask: 50.00 / 54.00   High: 53.75   Low: 52.01

Angle Plc Ord 10P Share News

Angle acquires outstanding shares in US subsidiary

5 Nov '18
... Angle said Monday it had acquired the outstanding shares in its US operating subsidiary Angle North America after reaching agreement to acquire Dr Georgi Hvichia's stake in the company.

Dr Georgi, the original inventor of the Parsortix microfluidic technology, had agreed to exchanged his Read More...

Angle acquires outstanding shares in US subsidiary5 Nov '18
Angle presents positive pre-natal testing study results in Massachusetts29 Oct '18
Angle's parsortix system shows evidence of circulating tumour cell clusters in glioblastoma 28 Aug '18
Angle losses deepen on increased investment spend25 Jul '18
Broker Forecast - finnCap issues a broker note on Angle PLC26 Jun '18
Angle says breast cancer FDA clinical study shows 'encouraging' progress4 Jun '18
Broker Forecast - finnCap issues a broker note on Angle PLC19 Apr '18
Angle revels breakthrough in capturing cancer cells19 Apr '18
Angle enrols first patient into its study for metastatic breast cancer 5 Apr '18
Angle collaborates with Abbott for cancer analysis research6 Feb '18
Angle reports operational losses widen 31 Jan '18
Angle PLC to present on 28 February 2018 at the Shares and AJ Bell Spotlight Evening in Edinburgh23 Jan '18
Angle PLC to present on 20 February 2018 at the Shares and AJ Bell Spotlight Evening in Manchester23 Jan '18
Professor to present webinar on use of ANGLE's Parsortix 16 Jan '18
ANGLE reports new research on Parsortix 8 Jan '18
Study shows out-performance of Parsortix, says ANGLE28 Nov '17
ANGLE collaboration with Philips 23 Nov '17
Angle to present on 28 November 2017 at the Shares and AJ Bell Spotlight Evening in London13 Nov '17
ANGLE completes Axela deal and fundraising 1 Nov '17
All resolutions passed at AGM of Angle31 Oct '17
Angle shareholders approve resolutions at GM30 Oct '17
ANGLE notes new report on Parsortix 23 Oct '17
ANGLE welcomes new peer review of Parsortix 17 Oct '17
ANGLE's Parsortix showcased at CTC conference9 Oct '17
ANGLE successfully raises £12.2m via placings5 Oct '17
ANGLE agrees Axela deal and raises £12.2m5 Oct '17
Broker Forecast - finnCap issues a broker note on Angle PLC5 Sep '17
ANGLE appoints Nomad 5 Sep '17
ANGLE welcomes new research on Parsortix 4 Sep '17
ANGLE losses widen 27 Jul '17
ANGLE confirms successful data in cancer studies 4 Jul '17
FTSE lower amid ex-divs ahead of BoE rate call15 Jun '17
Parsortix success reported at ASCO, says ANGLE 5 Jun '17
ANGLE Plc to present at the Growth and Innovation Forum 2017 in London on 31 January 20176 Jan '17
ANGLE schedules interims 4 Jan '17
ANGLE welcomes new research supporting Parsortix 4 Nov '16
ANGLE notes research results in Clinical Chemistry30 Sep '16
ANGLE revenue up28 Jul '16
ANGLE initiates ovarian cancer study in the US27 Jul '16
Edison research update on Angle27 May '16
ANGLE wins contract with Cancer Research UK25 May '16
Edison research update on Angle19 Apr '16
ANGLE's Parsortix potential in metastatic breast cancer18 Apr '16
ANGLE granted European patent for Parsortix9 Mar '16
UKE evaluation of ANGLE's Parsortix published 25 Jan '16
ANGLE confirms Parsortix first commercial sales15 Dec '15
ANGLE granted Canadian patent 14 Oct '15
ANGLE encouraged by new research data28 Sep '15
ANGLE Parsortix results to be presented at conference 9 Sep '15
ANGLE schedules FY results 20 Jul '15
Share Search
Share Search Share Search

Visit the Share Search.
Share Search

Share News
Share News will do their best to ensure the quality of the information displayed on this site, but all information is provided as-is, free of charge. We cannot be held responsible for any loss, material or otherwise, due to incorrect information found here. UK data supplied by NBTrader and Digital Look. Share Prices are at least 15 minutes delayed.